Eurofins Scientific Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Eurofins Scientific yıllık ortalama 8.2% oranında kazançlarını artırırken, Life Sciences sektöründe kazançlar growing at 13.9% annual. Gelirler growing yılda ortalama 8.8% oranında artmaktadır. Eurofins Scientific'in özkaynak karlılığı 7.1% ve net marjı 4.8%'dir.

Anahtar bilgiler

8.2%

Kazanç büyüme oranı

7.2%

EPS büyüme oranı

Life Sciences Sektör Büyümesi26.8%
Gelir büyüme oranı8.8%
Özkaynak getirisi7.1%
Net Marj4.8%
Sonraki Kazanç Güncellemesi26 Feb 2025

Yakın geçmiş performans güncellemeleri

Recent updates

Eurofins Scientific (EPA:ERF) Seems To Use Debt Quite Sensibly

Oct 21
Eurofins Scientific (EPA:ERF) Seems To Use Debt Quite Sensibly

Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)

Aug 17
Earnings Tell The Story For Eurofins Scientific SE (EPA:ERF)

Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts

Jul 27
Results: Eurofins Scientific SE Beat Earnings Expectations And Analysts Now Have New Forecasts

These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Extensively

May 10
These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Extensively

We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Apr 19
We Discuss Why Eurofins Scientific SE's (EPA:ERF) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings

Apr 18
Eurofins Scientific SE's (EPA:ERF) Price In Tune With Earnings

Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Nov 10
Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price

Oct 23
Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price

We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt

Aug 07
We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?

Jul 20
Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?

We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt

May 03
We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt

Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate

Apr 11
Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate

Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)

Jan 05
Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)

Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly

Dec 14
Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued

Oct 03
An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued

Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Sep 06
Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00

Jun 25
Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00

Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?

Jun 16
Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Jun 01
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?

Apr 12
Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?

These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely

Feb 25
These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely

Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?

Nov 28
Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Nov 14
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today

Sep 30
Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today

Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?

Aug 29
Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?

We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease

Aug 15
We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease

Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?

Jun 24
Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?

Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)

May 25
Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Mar 31
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?

Mar 17
Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?

Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock

Mar 03
Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock

Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Mar 03
Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?

Feb 15
Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?

Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?

Dec 28
Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?

Gelir ve Gider Dağılımı

Eurofins Scientific nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

ENXTPA:ERF Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 246,7243261330
31 Mar 246,6192911340
31 Dec 236,5152571360
30 Sep 236,5123351320
30 Jun 236,5104141280
31 Mar 236,6114971280
31 Dec 226,7125811280
30 Sep 226,7856121230
30 Jun 226,8576431170
31 Mar 226,7876961160
31 Dec 216,7187491150
30 Sep 216,5537861170
30 Jun 216,3888241180
31 Mar 215,9136651190
31 Dec 205,4395051190
30 Sep 205,0793471200
30 Jun 204,7191901200
31 Mar 204,6411681190
31 Dec 194,5631461170
30 Sep 194,3841441110
30 Jun 194,2051431060
31 Mar 193,993159980
31 Dec 183,781175900
30 Sep 183,549182820
30 Jun 183,318190750
31 Mar 183,145185620
31 Dec 172,971179480
30 Sep 172,848166420
30 Jun 172,725152350
31 Mar 172,631145370
31 Dec 162,537138380
30 Sep 162,427104350
30 Jun 162,31769320
31 Mar 162,13363310
31 Dec 151,95056300
30 Sep 151,77971270
30 Jun 151,60986240
31 Mar 151,50982200
31 Dec 141,41078150
30 Sep 141,35566170
30 Jun 141,29953190
31 Mar 141,26253150
31 Dec 131,22653120

Kaliteli Kazançlar: ERF büyük bir tek seferlik zarar ile €184.8M, 30th June, 2024 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: ERF 'nin mevcut net kar marjları (4.8%) geçen yılın (6.4%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: ERF şirketinin kazancı son 5 yılda yılda 8.2% oranında arttı.

Büyüme Hızlandırma: ERF 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: ERF geçtiğimiz yıl negatif kazanç büyümesine ( -21.3% ) sahipti ve bu da onu Life Sciences sektör ortalamasıyla ( 5.4% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: ERF 'nin Özsermaye Getirisi ( 7.1% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin